May 2024
Mar 2024
Dec 2023
May 2023
Philadelphia, PA., May 4, 2023– NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $15+ million Series Pre-A+ financing round.
Oct 2022